Search Tag: HIV-1

IMAGING Management

FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay

2017 18 Feb

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Hologic, Inc. (Nasdaq: HOLX) has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active... Read more

IMAGING Management

Hologic Launches First Fully Automated, Sample-to-Result Molecular Assay in Europe

2015 16 Dec

-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection --   Hologic, Inc. (Nasdaq: HOLX) has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated... Read more

IMAGING Management

Hologic Expands its European Virology Portfolio with CE-IVD Certified Assay for HBV Viral Load

2015 10 Dec

-- Aptima® HBV Quant Assay Joins Tests for HIV-1 and HCV on the Fully Automated Panther Instrument -- Hologic, Inc. (Nasdaq: HOLX) has earned CE-IVD certification for its Aptima HBV Quant assay on the fully automated Panther® instrument, the Company has announced.   This assay expands the European virology menu available on the Panther system,... Read more

Lab Management

Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA & HIV-1 Assays on DxN VERIS MDS

2015 10 Jun

—Beckman Coulter Diagnostics has obtained CE Marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV- 1)... Read more

Pharmacy Management

Powerful Anti-HIV Agent Can Work in a Vaccine

2015 23 Feb

Scientists from The Scripps Research Institute (TSRI) have announced the creation of a novel drug candidate that is so potent and universally effective that it could possibly work as part of an unconventional vaccine. The remarkable research involved scientists from more than a dozen research institutions and has been published in the journal... Read more